Article Text

This article has a correction. Please see:

other Versions

Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
  1. Andrew M Veitch (andrew.veitch{at}
  1. New Cross Hospital, United Kingdom
    1. Trevor P Baglin (trevor.baglin{at}
    1. Addenbrooke's Hospital, Cambridge, United Kingdom
      1. Anthony H Gershlick (agershlick{at}
      1. University Hospitals of Leicester, United Kingdom
        1. Sarah M Harnden (sarah.harnden{at}
        1. New Cross Hospital, Wolverhampton, United Kingdom
          1. Richard Tighe (richard.tighe{at}
          1. Norfolk and Norwich University Hosipital, Norwich, United Kingdom
            1. Stuart Cairns (stuart.cairns{at}
            1. Royal Sussex County Hospital, Brighton, United Kingdom


              This guideline deals primarily with elective endoscopic procedures. In the emergency situation of acute gastrointestinal haemorrhage, the immediate risk to the patient from haemorrhage may outweigh the risk of thrombosis as a result of discontinuing anticoagulant or antiplatelet therapy. If clopidogrel therapy for coronary artery stents needs to be discontinued in this context, then this should be limited to 5 days as the risk of stent thrombosis increases after this interval.

              Statistics from

              Request permissions

              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

              Linked Articles

              • Corrections
                BMJ Publishing Group Ltd and British Society of Gastroenterology